… therefore, identification of these rearrangements might have direct therapeutic relevance
to patients with thyroid cancer. Debate exists regarding the clinical implications of individual …

… , and radiotherapeutic records, with a follow-up time of at least 2 years, were included in this
study. Mixed papillary-follicular thyroid cancers … thyroid cancer, medullary thyroid cancer, or …

… patients treated with highactivity 131I for thyroid cancer and on prolonged follow-up have …
radiation dose received. The expectation of life of those dying from causes other than cancer …

… thyroid cancer is very slow, requiring a long follow-up in order to evaluate the results of any
treatment. In our series of 548 patients with differentiated thyroid cancers … radiotherapy and …

… was designed to evaluate the risk of second primary cancer in a cohort of thyroid cancer
patients treated with 13'I, and to contrast the risk with that of nonexposed thyroid cancer patients. …

… , intensity-modulated radiation therapy (IMRT). In this report, we review our institutional
treatment and morbidity outcomes for patients with differentiated thyroid cancer treated with these …

… thyroid cancers (WDTCs), poorly differentiated thyroid cancer (PDTC) and undifferentiated
thyroid cancer (… It is safe to commence radiation therapy as early as 2–3 weeks after surgery. …

… However, there is a subset of patients who are at high risk for local recurrence who may
benefit from adjuvant external radiation therapy. The difficulty in determining the optimal …

… carcinoma, resectable disease, and no distant metastases should be considered for
surgery and locoregional radiation therapy (with or without systemic therapy). Follow-up …

… therapy in selected groups. The role of external radiation therapy remains undefined in thyroid
cancer … patients with poor prognostic features of thyroid cancer. Hürthle cell tumors, which …